Stock Events

Stock Events

Telomir Pharmaceuticals (TELO) Q1 2025 Earnings

4FebConfirmed

Q4 2024

Q1 2025

-0.2

-0.16

-0.11

-0.07

Details

Expected EPS

-0.085

Actual EPS

-0.07

Surprise EPS

0.02

Surprise Percent

+17.65%

Description

Telomir Pharmaceuticals (TELO) has reported earnings of -0.07 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.